Gain Therapeutics, Inc. (GANX) Current Ratio % [USD] 2021 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Gain Therapeutics, Inc. quarterly Current Ratio history and growth rate from 2021 to 2024.
Gain Therapeutics, Inc. Current Ratio for the quarter ending March 31, 2024 was 292 %, a 45.2% decline year-over-year.

Current Ratio, Quarterly (% [USD])

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	292	-240	-45.2%	Mar 31, 2024
Q4 2023	315	-354	-52.9%	Dec 31, 2023
Q3 2023	344	-513	-59.8%	Sep 30, 2023
Q2 2023	427	-601	-58.4%	Jun 30, 2023
Q1 2023	532	-718	-57.4%	Mar 31, 2023
Q4 2022	669	-898	-57.3%	Dec 31, 2022
Q3 2022	857	-502	-37%	Sep 30, 2022
Q2 2022	1.03 K			Jun 30, 2022
Q1 2022	1.25 K			Mar 31, 2022
Q4 2021	1.57 K			Dec 31, 2021
Q3 2021	1.36 K			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.